CB2 receptors blocks accumulation of human hepatic myofibroblasts: a novel artifibrogenic pathway in the liver
US7320805B2 · kind B2 · utility
3Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 2004 |
| Grant date | Jan 22, 2008 |
| Priority date | — |
| Expiry date | Feb 3, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions for treating diseases mediated by CB2 receptors are disclosed, including fibrosis associated with liver injury.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.